Thyrotrophin releasing hormone and related peptides in canine tissues

in Journal of Endocrinology
Authors:
A. E. Pekary
Search for other papers by A. E. Pekary in
Current site
Google Scholar
PubMed
Close
,
Melvyn Richkind
Search for other papers by Melvyn Richkind in
Current site
Google Scholar
PubMed
Close
, and
J. M. Hershman
Search for other papers by J. M. Hershman in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

Thyrotrophin releasing hormone (TRH)-immunoreactive peptides have been quantified in canine serum, hypothalamus, liver, pancreas, adrenal, thyroid, prostate, testis, epididymis and semen by TRH radioimmunoassay, SP-Sephadex C-25 cation exchange chromatography, Sephadex G-10 exclusion chromatography and high pressure liquid chromatography. The total concentration of TRH and TRH-like peptides was highest in the hypothalamus, followed by liver, adrenal, pancreas, thyroid, prostate, epididymis, testis and serum. All of the TRH immunoreactivity (TRH-IR) within extracts of the hypothalamus was due to TRH. On the other hand, nearly all of the TRH-IR of extracts of liver, thyroid, prostate, epididymis, testis and semen was due to TRH-homologous peptides. Adrenal and pancreatic extracts contained a greater proportion of TRH in relation to the TRH-homologous peptides. Extracts of dog serum and semen were found to contain a TRH-binding substance which reduced the retention of added TRH by cation exchangers. The half-time of disappearance (t½) of synthetic TRH incubated at 23 °C in 10% (w/v) homogenates in 0·15 m-NaCl–0·05 m-phosphate buffer, pH 7·5, ranged from 22±10 (s.d.) min for liver to 120 ±58 min for thyroid. The short t½ for TRH added to dog liver homogenates contrasted with a previous report that dog liver is essentially free of TRH-degrading activity.

 

  • Collapse
  • Expand